noom glp 1 microdose reviews GLP-1 Review 2026: Great App but Hidden Costs Noom Med Plans & Pricing
Description
Government resistance to subsidising obesity medications and rising public scrutiny may slow broader uptake, despite clinical success and commercial demand
However, it must maintain its edge in clinical data and product differentiation to stay ahead of its competitors
Innovator Novo Nordisk launched its semaglutide brands Wegovy and Ozempic in India last year, racing to capture early market share before losing patent exclusivity on 20 March 2026
Should You Take Mounjaro or Ozempic
Statements Author contributions All the authors contributed equally to the writing, revision, and editing of this manuscript
